Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Ultragenyx Pharmaceutical (RARE) and Opthea Limited Sponsored ADR (OPT)
TipRanksApr 8 03:40 ET
Buy Rating for Opthea Limited on Promising Phase 2b Results of Sozinibercept for Wet AMD
TipRanksFeb 29 06:28 ET
Opthea Limited's Strong Financial Standing and Promising Drug Candidate Secure a Buy Rating: An Analysis by Chris Cooper
TipRanksOct 17, 2023 04:17 ET
JonesTrading Sticks to Its Buy Rating for Opthea Limited Sponsored ADR (OPT)
TipRanksSep 14, 2023 16:55 ET
Opthea Analyst Ratings
BenzingaSep 13, 2023 12:20 ET
Oppenheimer Cuts Opthea Price Target to $16 From $31, Maintains Outperform Rating
MT NewswiresSep 13, 2023 08:42 ET
Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN), Mirati Therapeutics (MRTX) and Opthea Limited Sponsored ADR (OPT)
TipRanksSep 13, 2023 08:40 ET
H.C. Wainwright Remains a Buy on Opthea Limited Sponsored ADR (OPT)
TipRanksAug 1, 2023 06:15 ET
HC Wainwright & Co. Reiterates Buy on Opthea, Maintains $14 Price Target
BenzingaAug 1, 2023 06:14 ET
Opthea Analyst Ratings
BenzingaAug 1, 2023 06:13 ET
Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF) and Glaukos (GKOS)
TipRanksJul 26, 2023 22:10 ET
Analysts Offer Insights on Healthcare Companies: Opthea Limited Sponsored ADR (OPT) and Humacyte (HUMA)
TipRanksApr 27, 2023 16:46 ET
EF Hutton Starts Opthea at Buy With $23 Price Target
MT NewswiresApr 17, 2023 09:33 ET
EF Hutton Initiates Coverage On Opthea With Buy Rating, Announces Price Target of $23
BenzingaApr 17, 2023 08:42 ET
Oppenheimer Adjusts Opthea's Price Target to $31 From $36, Maintains Outperform Rating
MT NewswiresMar 13, 2023 09:02 ET
Oppenheimer Maintains Outperform on Opthea, Lowers Price Target to $31
BenzingaMar 13, 2023 08:29 ET
Opthea Limited Sponsored ADR (OPT) Receives a Buy From SVB Securities
TipRanksFeb 27, 2023 00:11 ET
H.C. Wainwright Keeps Their Buy Rating on Opthea Limited Sponsored ADR (OPT)
TipRanksFeb 24, 2023 06:31 ET
HC Wainwright & Co. Reiterates Buy on Opthea, Maintains $14 Price Target
BenzingaFeb 24, 2023 06:24 ET
SVB Securities Sticks to Its Buy Rating for Opthea Limited Sponsored ADR (OPT)
TipRanksOct 12, 2022 02:20 ET
No Data
No Data